TScan Therapeutics Inc. (TCRX)
1.27
-0.11 (-7.97%)
At close: Apr 01, 2025, 3:59 PM
1.31
3.16%
After-hours: Apr 01, 2025, 07:59 PM EDT
TScan Therapeutics Revenue
TScan Therapeutics reported an annual revenue of $2.82M, reflecting a -86.62% growth. For the quarter ending December 31, 2024, TScan Therapeutics generated $665K in revenue.
Revenue (ttm)
$2.82M
Revenue Growth
-86.62%
Price / Sales Ratio
120.9
Revenue / Employee
$14.52K
Employees
194
Market Cap
71.87M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 2.82M | -86.62% |
| Dec 31, 2023 | 21.05M | +55.52% |
| Dec 31, 2022 | 13.54M | +33.47% |
| Dec 31, 2021 | 10.14M | +834.65% |
| Dec 31, 2020 | 1.08M | n/a |